Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03896503
Title Topotecan With or Without M6620 in Treating Patients With Relapsed Small Cell Lung Cancer or Extrapulmonary Small Cell Cancer
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

urinary bladder small cell neuroendocrine carcinoma

lung small cell carcinoma

prostate small cell carcinoma



Berzosertib + Topotecan

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.